Home › Companies › LEXICON PHARMACEUTICALS INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and LEXICON PHARMACEUTICALS INC.’s Form 8-K, filed May 10, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 10, 2024: 6 items on LEXICON PHARMACEUTICALS INC.’s Form 8-K, filed May 10, 2024: 6 passed (calculated).
No notable dissent.
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore LEXICON PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are LEXICON PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 10, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Philippe J. Amouyal | 241,812,501 | -- | -- | 18,607,732 | 29,015,729 | 93% | Passed (calculated) | — |
| Elect Director: Lonnel Coats | 247,448,636 | -- | -- | 12,971,597 | 29,015,729 | 95% | Passed (calculated) | — |
| Elect Director: Diane E. Sullivan | 259,435,040 | -- | -- | 985,193 | 29,015,729 | 99.6% | Passed (calculated) | — |
| 2. Ratification and approval of the Company's Sixth Amended and Restated Certificate of Incorporation | 160,676,391 | 1,433,806 | 211,035 | -- | -- | 99.1% | Passed (calculated) | — |
| 3. Advisory vote to approve the compensation paid to the Company’s named executive officers | 253,593,322 | 6,203,593 | 623,318 | -- | 29,015,729 | 98% | Passed (calculated) | — |
| 4. Ratification and approval of the appointment of Ernst & Young LLP as Company's independent auditors for the fiscal year ending December 31, 2024 | 286,136,766 | 2,884,465 | 414,731 | -- | -- | 99.0% | Passed (calculated) | — |
Source: LEXICON PHARMACEUTICALS INC., Form 8-K, filed with the SEC on May 10, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
110 asset managers disclosed a vote on at least one LEXICON PHARMACEUTICALS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Diane E. Sullivan
LEXICON PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Diane E. Sullivan”): 259,435,040 for, 985,193 withheld, per its Form 8-K filed May 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.6% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 12,324,218 for, 8,867 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,496,030 | 0 | 0 | 0 | For |
| BlackRock | 2,813,804 | 0 | 0 | 0 | For |
| Vanguard | 2,190,262 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,204,203 | 0 | 0 | 0 | For |
| Charles Schwab | 616,297 | 0 | 0 | 0 | For |
| TIAA | 592,515 | 0 | 0 | 0 | For |
| JPMorgan | 478,651 | 0 | 0 | 0 | For |
| Equitable | 240,312 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 159,505 | 0 | 0 | 0 | For |
| Lincoln Financial | 76,516 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 60,801 | 0 | 0 | 0 | For |
| Northern Trust | 51,996 | 0 | 0 | 0 | For |
| Dimensional | 47,381 | 0 | 0 | 0 | For |
| Invesco | 38,591 | 0 | 0 | 0 | For |
| ProShares | 33,538 | 0 | 0 | 0 | For |
| Pacific Life | 32,246 | 0 | 0 | 0 | For |
| Altium Capital Management LP | 27,650 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 26,636 | 0 | 0 | 0 | For |
| Brighthouse | 26,469 | 0 | 0 | 0 | For |
| SEI | 17,105 | 0 | 0 | 0 | For |
| Prudential/PGIM | 15,609 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,945 | 0 | 0 | 0 | For |
| DWS | 14,403 | 0 | 0 | 0 | For |
| Principal | 10,534 | 0 | 0 | 0 | For |
| Voya | 9,063 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Lonnel Coats
LEXICON PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Lonnel Coats”): 247,448,636 for, 12,971,597 withheld, per its Form 8-K filed May 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 11,489,113 for, 843,672 withheld, 300 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,496,030 | 0 | 0 | 0 | For |
| BlackRock | 2,813,804 | 0 | 0 | 0 | For |
| Vanguard | 2,190,262 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,204,203 | 0 | 0 | 0 | For |
| Charles Schwab | 616,297 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 592,515 | Withhold |
| JPMorgan | 478,651 | 0 | 0 | 0 | For |
| Equitable | 240,312 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 159,505 | 0 | 0 | 0 | For |
| Lincoln Financial | 76,516 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 0 | 0 | 60,801 | Withhold |
| Northern Trust | 51,996 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 47,381 | Withhold |
| Invesco | 0 | 0 | 0 | 38,591 | Withhold |
| ProShares | 0 | 0 | 0 | 33,538 | Withhold |
| Pacific Life | 32,246 | 0 | 0 | 0 | For |
| Altium Capital Management LP | 27,650 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 26,636 | 0 | 0 | 0 | For |
| Brighthouse | 9,582 | 0 | 0 | 16,887 | Mixed |
| SEI | 17,105 | 0 | 0 | 0 | For |
| Prudential/PGIM | 15,609 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 14,945 | Withhold |
| DWS | 0 | 0 | 0 | 14,403 | Withhold |
| Principal | 0 | 0 | 0 | 10,534 | Withhold |
| Voya | 9,063 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Philippe J. Amouyal
LEXICON PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Philippe J. Amouyal”): 241,812,501 for, 18,607,732 withheld, per its Form 8-K filed May 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 8,154,872 for, 4,151,277 withheld, 26,936 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,496,030 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 0 | 2,813,804 | Withhold |
| Vanguard | 2,190,262 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,204,203 | 0 | 0 | 0 | For |
| Charles Schwab | 616,297 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 592,515 | Withhold |
| JPMorgan | 478,651 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 0 | 240,312 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 159,505 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 76,516 | Withhold |
| ETFis Series Trust I | 0 | 0 | 0 | 60,801 | Withhold |
| Northern Trust | 51,996 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 47,381 | Withhold |
| Invesco | 38,591 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 33,538 | Withhold |
| Pacific Life | 0 | 0 | 0 | 32,246 | Withhold |
| Altium Capital Management LP | 27,650 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 0 | 0 | 26,636 | 0 | Abstain |
| Brighthouse | 9,582 | 0 | 0 | 16,887 | Mixed |
| SEI | 17,105 | 0 | 0 | 0 | For |
| Prudential/PGIM | 15,609 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 14,945 | Withhold |
| DWS | 0 | 0 | 0 | 14,403 | Withhold |
| Principal | 0 | 0 | 0 | 10,534 | Withhold |
| Voya | 0 | 0 | 0 | 9,063 | Withhold |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
LEXICON PHARMACEUTICALS INC.’s own tally for this item (“2. Ratification and approval of the the Company's Sixth Amended and Restated Certificate of Incorporation”): 160,676,391 for, 1,433,806 against, per its Form 8-K filed May 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 12,333,085 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,496,030 | 0 | 0 | 0 | For |
| BlackRock | 2,813,804 | 0 | 0 | 0 | For |
| Vanguard | 2,190,262 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,204,203 | 0 | 0 | 0 | For |
| Charles Schwab | 616,297 | 0 | 0 | 0 | For |
| TIAA | 592,515 | 0 | 0 | 0 | For |
| JPMorgan | 478,651 | 0 | 0 | 0 | For |
| Equitable | 240,312 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 159,505 | 0 | 0 | 0 | For |
| Lincoln Financial | 76,516 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 60,801 | 0 | 0 | 0 | For |
| Northern Trust | 51,996 | 0 | 0 | 0 | For |
| Dimensional | 47,381 | 0 | 0 | 0 | For |
| Invesco | 38,591 | 0 | 0 | 0 | For |
| ProShares | 33,538 | 0 | 0 | 0 | For |
| Pacific Life | 32,246 | 0 | 0 | 0 | For |
| Altium Capital Management LP | 27,650 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 26,636 | 0 | 0 | 0 | For |
| Brighthouse | 26,469 | 0 | 0 | 0 | For |
| SEI | 17,105 | 0 | 0 | 0 | For |
| Prudential/PGIM | 15,609 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,945 | 0 | 0 | 0 | For |
| DWS | 14,403 | 0 | 0 | 0 | For |
| Principal | 10,534 | 0 | 0 | 0 | For |
| Voya | 9,063 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Advisory vote to approve the compensation paid to the Company's named executive officers
LEXICON PHARMACEUTICALS INC.’s own tally for this item (“3. Advisory vote to approve the compensation paid to the Company’s named executive officers”): 253,593,322 for, 6,203,593 against, per its Form 8-K filed May 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,496,030 | 0 | 0 | 0 | For |
| BlackRock | 2,813,804 | 0 | 0 | 0 | For |
| Vanguard | 2,190,262 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 1,204,203 | 0 | 0 | Against |
| Charles Schwab | 616,297 | 0 | 0 | 0 | For |
| TIAA | 592,515 | 0 | 0 | 0 | For |
| JPMorgan | 478,651 | 0 | 0 | 0 | For |
| Equitable | 20,371 | 219,941 | 0 | 0 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 159,505 | 0 | 0 | 0 | For |
| Lincoln Financial | 76,516 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 60,801 | 0 | 0 | 0 | For |
| Northern Trust | 51,996 | 0 | 0 | 0 | For |
| Dimensional | 0 | 47,381 | 0 | 0 | Against |
| Invesco | 38,591 | 0 | 0 | 0 | For |
| ProShares | 33,538 | 0 | 0 | 0 | For |
| Pacific Life | 32,246 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 26,636 | 0 | 0 | 0 | For |
| Brighthouse | 26,469 | 0 | 0 | 0 | For |
| SEI | 0 | 17,105 | 0 | 0 | Against |
| Prudential/PGIM | 15,609 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,945 | 0 | 0 | 0 | For |
| DWS | 14,403 | 0 | 0 | 0 | For |
| Principal | 10,534 | 0 | 0 | 0 | For |
| Voya | 9,063 | 0 | 0 | 0 | For |
| Texas Capital Funds Trust | 8,895 | 0 | 0 | 0 | For |
Fund voting reports, all 36 managers: 10,807,937 for, 1,497,498 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Point72 | 9,216,600 | 0 | 0 | 0 | For |
| Fidelity | 8,502,327 | 0 | 0 | 0 | For |
| BlackRock | 2,227,023 | 7,099 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 1,771,810 | 0 | 0 | 0 | For |
| State Street | 1,397,255 | 349 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 0 | 804,111 | 0 | 0 | Against |
| JPMorgan | 752,916 | 0 | 0 | 0 | For |
| Charles Schwab | 616,297 | 0 | 0 | 0 | For |
| Nuveen | 594,382 | 0 | 0 | 0 | For |
| Wellington | 0 | 568,106 | 0 | 0 | Against |
| PINNACLE ASSOCIATES LTD | 531,690 | 0 | 0 | 0 | For |
| Northern Trust | 464,397 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 219,941 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 197,839 | 0 | 0 | 0 | For |
| AMERIPRISE FINANCIAL INC | 0 | 175,849 | 0 | 0 | Against |
| Vanguard | 105,171 | 0 | 0 | 0 | For |
| STIFEL NICOLAUS & CO INC \MO\ | 101,332 | 0 | 0 | 0 | For |
| BBR PARTNERS, LLC | 100,000 | 0 | 0 | 0 | For |
| Cerity Partners LLC | 0 | 95,512 | 0 | 0 | Against |
| GREAT POINT PARTNERS LLC | 92,165 | 0 | 0 | 0 | For |
| Natixis | 0 | 86,788 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 72,285 | 0 | 0 | 0 | For |
| Goldman Sachs | 62,185 | 0 | 0 | 0 | For |
| Invesco | 62,178 | 0 | 0 | 0 | For |
| Two Sigma | 60,442 | 0 | 0 | 0 | For |
Institutional-manager reports, all 90 managers: 27,229,678 for, 2,142,639 against, 3,300 withheld. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
Description as filed by funds: Ratification and approval of the appointment of Ernst & Young LLP as the Company's independent auditors for the fiscal year ending December 31, 2024
LEXICON PHARMACEUTICALS INC.’s own tally for this item (“4. Ratification and approval of the appointment of Ernst & Young LLP as Company's independent auditors for the fiscal year ending December 31, 2024”): 286,136,766 for, 2,884,465 against, per its Form 8-K filed May 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 12,333,085 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,496,030 | 0 | 0 | 0 | For |
| BlackRock | 2,813,804 | 0 | 0 | 0 | For |
| Vanguard | 2,190,262 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,204,203 | 0 | 0 | 0 | For |
| Charles Schwab | 616,297 | 0 | 0 | 0 | For |
| TIAA | 592,515 | 0 | 0 | 0 | For |
| JPMorgan | 478,651 | 0 | 0 | 0 | For |
| Equitable | 240,312 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 159,505 | 0 | 0 | 0 | For |
| Lincoln Financial | 76,516 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 60,801 | 0 | 0 | 0 | For |
| Northern Trust | 51,996 | 0 | 0 | 0 | For |
| Dimensional | 47,381 | 0 | 0 | 0 | For |
| Invesco | 38,591 | 0 | 0 | 0 | For |
| ProShares | 33,538 | 0 | 0 | 0 | For |
| Pacific Life | 32,246 | 0 | 0 | 0 | For |
| Altium Capital Management LP | 27,650 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 26,636 | 0 | 0 | 0 | For |
| Brighthouse | 26,469 | 0 | 0 | 0 | For |
| SEI | 17,105 | 0 | 0 | 0 | For |
| Prudential/PGIM | 15,609 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,945 | 0 | 0 | 0 | For |
| DWS | 14,403 | 0 | 0 | 0 | For |
| Principal | 10,534 | 0 | 0 | 0 | For |
| Voya | 9,063 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 246,236,753 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 1.42% |
| 2 | BlackRock | 1.14% |
| 3 | Vanguard | 0.89% |
| 4 | Columbia Threadneedle | 0.49% |
| 5 | Charles Schwab | 0.25% |
| 6 | TIAA | 0.24% |
| 7 | JPMorgan | 0.19% |
| 8 | Equitable | 0.10% |
| 9 | QUANTITATIVE MASTER SERIES LLC | 0.06% |
| 10 | Lincoln Financial | 0.03% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Point72 | 3.74% |
| 2 | Fidelity | 3.45% |
| 3 | BlackRock | 0.91% |
| 4 | ORBIMED ADVISORS LLC | 0.72% |
| 5 | State Street | 0.57% |
| 6 | PNC BANK, NATIONAL ASSOCIATION | 0.33% |
| 7 | JPMorgan | 0.31% |
| 8 | Charles Schwab | 0.25% |
| 9 | Nuveen | 0.24% |
| 10 | Wellington | 0.23% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Invus, L.P., Invus Public Equities, L.P., Invus US Partners, LLC and Artal International S | 180,550,588 | — | Proxy statement (DEF 14A), proxy filed March 26, 2024 |
| FMR (Fidelity) | 38,679,748 | — | Form 13F, quarter ended March 31, 2024 |
| FMR LLC | 36,935,512 | — | Proxy statement (DEF 14A), proxy filed March 26, 2024 |
| Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., Biotechnology Value Tra | 24,435,632 | — | Proxy statement (DEF 14A), proxy filed March 26, 2024 |
| Vanguard Group | 9,521,874 | — | Form 13F, quarter ended March 31, 2024 |
| Raymond Debbane | 6,792,051 | — | Proxy statement (DEF 14A), proxy filed March 26, 2024 |
| BlackRock | 3,394,972 | — | Form 13F, quarter ended March 31, 2024 |
| Geode Capital | 2,389,137 | — | Form 13F, quarter ended March 31, 2024 |
| State Street | 1,987,510 | — | Form 13F, quarter ended March 31, 2024 |
| Lonnel Coats | 1,098,068 | — | Proxy statement (DEF 14A), proxy filed March 26, 2024 |
Percentages above are of 246,236,753 shares outstanding, as reported by LEXICON PHARMACEUTICALS INC. on its Form 10-Q dated April 29, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At LEXICON PHARMACEUTICALS INC.'s shareholder meeting held May 10, 2024, in the 2023-2024 proxy season, 110 asset managers reported votes on at least one of its 6 ballot items in their SEC Form N-PX filings, covering 809 separate fund positions. On the most widely held item on that ballot — Advisory vote to approve the compensation paid to the Company's named executive officers — FOR was 98% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: LEXICON PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 10, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from LEXICON PHARMACEUTICALS INC.’s 10-Q dated April 29, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
LEXICON PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “LEXICON PHARMACEUTICALS (LXRX) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/lexicon-pharmaceuticals-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.